Stroke Management Market
Global Stroke Management Market Research By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke and Transient Ischemic Attack (TIA), By Diagnosis Method (Imaging Method and Blood Test), and By Therapeutics (Intravenous Injection of Tissue Plasminogen Activator (TPA), Antiplatelet, Anticoagulant and Antihypertensive) Forecast 2021-2027
The global stroke management market is growing at a considerable CAGR of 6.9% during the forecast period. Rising air pollution increases the risk related to stroke is one of the prime factors affecting and driving the market. The increasing population with high cholesterol and diabetes along with changing lifestyle and faulty dietary habits is also estimated to be the prime factors that are contributing significantly towards the growth of the market. However, high-cost involvement in treatment is one of the major factors constraints that is hindering the growth of the global stroke management market across the globe.
Further, the development of strong pipeline products along with technology advancement in stent relievers is the key factor that is creating opportunities for the market. New product launches and collaboration in the market are likely to drive the growth of the global stroke management market. For instance, in January 2021, Koninklijke Philips N.V. one of the global providers in health technology had done partnership for 5 years with one of leading France’s hospitals named Rennes University Hospital. Through this partnership, the hospital will have access to the latest technology and informatics solution provided by Koninklijke Philips N.V. in order to do diagnosis and treatment along with monitoring the patients. Additionally, clinical research would also be boosted in therapy and neurology.
Impact of COVID-19 on the Global Stroke Management Market
The global stroke management market is hardly hit by the COVID-19 pandemic since December 2019. The COVID-19 pandemic in the major economies has disrupted various activities. However, the proper treatment was been given by physicians to patients suffering from stroke and cardiovascular diseases.
Segmental Outlook
The market is segmented based on stroke type, diagnosis method, therapeutics. Based on stroke type, the market is segmented into ischemic stroke, hemorrhagic stroke, and transient ischemic attack (TIA). By diagnosis method, the market is segmented into imaging method and blood test. Further, by therapeutics, the market is segmented into intravenous injection of tissue plasminogen activator (TPA), antiplatelet, anticoagulant, and antihypertensive.
Global Stroke Management Market Share by Diagnosis method 2020 (%)
Based on the diagnosis method, the imaging method is one of the important methods adopted in order to manage the diagnosis related to the stroke. Through this imaging method, key information can be easily received with regard to stroke. The method includes computed tomography scan (CT scan), magnetic resonance imaging (MRI), and carotid ultrasound among others.
Regional Outlooks
The global stroke management market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global stroke management market. Some factors that are boosting the market growth in North America are the increasing pervasiveness of cardiovascular diseases. For instance, according to the US Department of Health & Human Services, every year around 7,95,000 people suffer from stroke in the US. Additionally, increasing investment in medical care in the region along with increasing awareness related to stroke are boosting the market.
Global Stroke Management Market, by Region 2021-2027
Asia-Pacific will have Considerable Growth in the Global Stroke Management Market
Asia-Pacific region is expected to witness significant growth opportunities for the market. The increasing pervasiveness of strokes along with rising awareness related to strokes and CVDs in emerging economies of the region are likely to drive the growth of the regional market. Further due to increased usage of tobacco and unhealthy dietary habits in India, China and South Korea are also some of the factors that are affecting and impacting the growth in this market.
Market Player Outlook
Key players of the global stroke management market are Abbott, Cardinal Health, Johnson & Johnson Services, Inc, Medtronic, Siemens Healthcare Pvt. Ltd., among others. To survive in the market, these players adopt different marketing strategies such as product launches and collaboration. For instance, in October 2020, Amgen Inc. had got into partnership with two NHS organizations. This collaboration would support the company across the northwest coast of England in order to deal with the silent killer of high cholesterol. This area is highly affected by heart attack, strokes along with deaths that are pre-mature due to diseases such as cardiovascular.
In October 2020, Acticor Biotech SAS which is one of the clinical-stage biotechnology companies had set forth the completion of its ACTIMIS dose-escalation phase first. This was done for patients suffering from acute ischemic stroke and 60 patients enrolled from 6 European countries that include France, Belgium, and Germany among others.
In July 2020, AstraZeneca had set forth that US Food and Drug Administration (FDA) had given acceptance to its supplemental New Drug Application (sNDA) and for Brilinta (ticagrelor). Brilinta got a priority review for patients who had experienced an acute ischemic stroke or transient ischemic attack (TIA) as it decreases the subsequent.
In March 2019, an initiative was launched by Amgen Inc. named Cholesterol 911. Through this initiative, the company would urge the patients suffering from high-risk cardiovascular diseases (CVD) in order to reduce their risk of another heart attack by managing their increased cholesterol.
The Report Covers
• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global stroke management market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Stroke Management Industry
• Recovery Scenario of Global Stroke Management Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Stroke Management Market by Stroke Type
5.1.1. Ischemic Stroke
5.1.2. Hemorrhagic Stroke
5.1.3. Transient Ischemic Attack (TIA)
5.2. Global Stroke Management Market by Diagnosis Method
5.2.1. Imaging Method
5.2.2. Blood Test
5.3. Global Stroke Management Market by Therapeutics
5.3.1. Intravenous Injection of Tissue Plasminogen Activator (TPA)
5.3.2. Antiplatelet
5.3.3. Anticoagulant
5.3.4. Antihypertensive
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott
7.2. Acticor Biotech SAS
7.3. Amgen Inc.
7.4. AstraZeneca
7.5. Boston Scientific Corp.
7.6. Cardinal Health.
7.7. DAIICHI SANKYO CO., LTD
7.8. EVER NEURO PHARMA GMBH
7.9. General Electric
7.10. Johnson & Johnson Services, Inc
7.11. Koninklijke Philips N.V.
7.12. Medtronic
7.13. Merck KgaA
7.14. Siemens Healthcare Pvt.Ltd.
7.15. Stryker
7.16. Terumo Corp.
7.17. W. L. Gore & Associates, Inc.
7.18. Zocere, Inc.
1. GLOBAL STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
2. GLOBAL STROKE MANAGEMENT MARKET BY STROKE TYPE, 2020-2027($ MILLION)
3. GLOBAL ISCHEMIC STROKE MARKET BY REGION, 2020-2027($ MILLION)
4. GLOBAL HEMORRHAGIC STROKE MARKET BY REGION, 2020-2027($ MILLION)
5. GLOBAL TRANSIENT ISCHEMIC ATTACK (TIA) MARKET BY REGION, 2020-2027($ MILLION)
6. GLOBAL STROKE MANAGEMENT MARKET BY DIAGNOSIS METHOD, 2020-2027($ MILLION)
7. GLOBAL IMAGING METHOD MARKET BY REGION, 2020-2027($ MILLION)
8. GLOBAL BLOOD TEST MARKET BY REGION, 2020-2027($ MILLION)
9. GLOBAL STROKE MANAGEMENT MARKET BY THERAPEUTICS, 2020-2027($ MILLION)
10. GLOBAL INTRAVENOUS INJECTION OF TISSUE PLASMINOGEN ACTIVATOR (TPA) MARKET BY REGION, 2020-2027($ MILLION)
11. GLOBAL ANTIPLATELET MARKET BY REGION, 2020-2027($ MILLION)
12. GLOBAL ANTICOAGULANT MARKET BY REGION, 2020-2027($ MILLION)
13. GLOBAL ANTIHYPERTENSIVE MARKET BY REGION, 2020-2027($ MILLION)
14. GLOBAL STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLION)
15. NORTH AMERICAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
16. NORTH AMERICAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY STROKE TYPE, 2020-2027($ MILLION)
17. NORTH AMERICAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2020-2027($ MILLION)
18. NORTH AMERICAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2020-2027($ MILLION)
19. EUROPEAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
20. EUROPEAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY STROKE TYPE, 2020-2027($ MILLION)
21. EUROPEAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2020-2027($ MILLION)
22. EUROPEAN STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2020-2027($ MILLION)
23. ASIA-PACIFIC STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
24. ASIA-PACIFIC STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY STROKE TYPE, 2020-2027($ MILLION)
25. ASIA-PACIFIC STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2020-2027($ MILLION)
26. ASIA-PACIFIC STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2020-2027($ MILLION)
27. REST OF WORLD STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY STROKE TYPE,2020-2027($ MILLION)
28. REST OF WORLD STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2020-2027($ MILLION)
29. REST OF WORLD STROKE MANAGEMENT MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2020-2027($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL STROKE MANAGEMENT MARKET, 2020-2027 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL STROKE MANAGEMENT MARKET SHARE BY SEGMENT, 2020-2027 ($ MILLION)
3. RECOVERY OF GLOBAL STROKE MANAGEMENT MARKET, 2021-2027 (%)
1. GLOBAL STROKE MANAGEMENT MARKET BY STROKE TYPE,2020 VS 2027 (%)
2. GLOBAL STROKE MANAGEMENT MARKET BY DIAGNOSIS, 2020 VS 2027 (%)
3. GLOBAL STROKE MANAGEMENT MARKET BY THERAPEUTICS 2020 VS 2027 (%)
4. GLOBAL STROKE MANAGEMENT MARKET BY GEOGRAPHY, 2020 VS 2027 (%)
5. GLOBAL ISCHEMIC STROKE MARKET BY REGION, 2020 VS 2027 (%)
6. GLOBAL HEMORRHAGIC STROKE MARKET BY REGION, 2020 VS 2027 (%)
7. GLOBAL TRANSIENT ISCHEMIC ATTACK (TIA) MARKET BY REGION, 2020 VS 2027 (%)
8. GLOBAL IMAGING METHOD MARKET BY REGION, 2020 VS 2027 (%)
9. GLOBAL BLOOD TEST MARKET BY REGION, 2020 VS 2027 (%)
10. GLOBAL INTRAVENOUS INJECTION OF TISSUE PLASMINOGEN ACTIVATOR (TPA) BY REGION, 2020 VS 2027 (%)
11. GLOBAL ANTIPLATELET MARKET BY REGION, 2020 VS 2027 (%)
12. GLOBAL ANTICOAGULANT MARKET BY REGION, 2020 VS 2027 (%)
13. GLOBAL ANTIHYPERTENSIVE MARKET BY REGION, 2020 VS 2027 (%)
14. US STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
15. CANADA STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
16. UK STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
17. FRANCE STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
18. GERMANY STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
19. ITALY STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
20. SPAIN STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
21. REST OF EUROPE STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
22. INDIA STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
23. CHINA STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
24. JAPAN STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
25. SOUTH KOREA STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
26. REST OF ASIA-PACIFIC STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
27. REST OF THE WORLD STROKE MANAGEMENT MARKET SIZE, 2020-2027 ($ MILLION)
